Development of quality indicators for chronic obstructive pulmonary disease (COPD): A modified RAND appropriateness method

被引:7
|
作者
Gershon, Andrea S. [1 ,2 ,3 ,4 ,5 ]
Mecredy, Graham C. [2 ]
Aaron, Shawn D. [6 ]
Camp, Pat G. [7 ,8 ]
Tu, Karen [5 ,9 ,10 ]
Hernandez, Paul [11 ,12 ]
To, Teresa [3 ,5 ,13 ]
机构
[1] Sunnybrook Hlth Sci Ctr, G1 06,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada
[2] Inst Clin Evaluat Sci, Toronto, ON, Canada
[3] Univ Toronto, Dept Med, Toronto, ON, Canada
[4] Hosp Sick Children, Res Inst, Toronto, ON, Canada
[5] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[6] Univ Ottawa, Ottawa Hosp, Clin Epidemiol, Res Inst, Ottawa, ON, Canada
[7] Univ British Columbia, Ctr Heart Lung Innovat, Vancouver, BC, Canada
[8] Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada
[9] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada
[10] Univ Hlth Network, Toronto Western Hosp, Toronto, ON, Canada
[11] Dalhousie Univ, Dept Med, Halifax, NS, Canada
[12] Queen Elizabeth 2 Hlth Sci Ctr, Div Respirol, Halifax, NS, Canada
[13] Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
Chronic obstructive pulmonary disease (COPD); health care; quality indicators; quality assurance; quality improvement; OF-CARE; ADHERENCE; RISK; MANAGEMENT;
D O I
10.1080/24745332.2018.1476030
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
RATIONALE: Quality indicators are evidence-based structures, processes and outcomes of care associated with such a strong benefit that failure to address them reduces likelihood of good health outcomes. OBJECTIVES: Our objective was to use synthesized evidence and diverse expert opinion to create a comprehensive set of evidence-based COPD quality indicators spanning the health care continuum from prevention to outcome. METHODS: COPD quality indicators were developed using a modified RAND Appropriateness Method consisting of a systematic review of the medical literature followed by a Delphi method survey. The review took place in three parts: searching first for existing high quality COPD quality indicators, then for meta-analyses and systematic reviews and, lastly, for individual studies. The Delphi method had an expert panel rate and discussed the indicators in an in-person meeting followed by rounds of electronic surveys until consensus was reached. RESULTS: The systematic review produced 26 highly rated quality indicators, and 10,002 titles for further assessment. Of these, 32 full-text articles provided supporting evidence for 39 additional COPD quality indicators, for 65 in total. After rounds of review by the expert panel, a final list of 33 quality indicators was endorsed by all. CONCLUSIONS: We generated a comprehensive set of 33 evidence-based COPD quality indicators. These can be used to measure current quality of COPD health and healthcare, develop and implement strategies to improve it and otherwise provide a foundation for quality improvement. Before using in other jurisdictions, these made-in-Canada indicators should be validated to ensure they address their unique circumstances.
引用
收藏
页码:30 / 38
页数:9
相关论文
共 50 条
  • [31] Bronchodilators in chronic obstructive pulmonary disease (COPD)
    Gillissen, A
    Buhl, R
    Rabe, KF
    Vogelmeier, C
    Welte, J
    MEDIZINISCHE KLINIK, 2005, 100 (05) : 246 - 254
  • [32] Epidemiology of Chronic Obstructive Pulmonary Disease (COPD)
    Viegi, G
    Scognamiglio, A
    Baldacci, S
    Pistelli, F
    Carrozzi, L
    RESPIRATION, 2001, 68 (01) : 4 - 19
  • [33] Chronic obstructive pulmonary disease (COPD) in the elderly
    Orvoen-Frija, E.
    Benoit, M.
    Catto, M.
    Chambouleyron, M.
    Duguet, A.
    Emeriau, J-P
    Ferry, M.
    Hayot, M.
    Jeandel, C.
    Morize, V.
    Nassih, K.
    Ouksel, H.
    Piette, F.
    Prefaut, C.
    Roche, N.
    de Wazieres, B.
    Zureik, M.
    REVUE DES MALADIES RESPIRATOIRES, 2010, 27 (08) : 855 - 873
  • [34] Exercise and Chronic Obstructive Pulmonary Disease (COPD)
    Fiorentino, Giuseppe
    Esquinas, Antonio M.
    Annunziata, Anna
    PHYSICAL EXERCISE FOR HUMAN HEALTH, 2020, 1228 : 355 - 368
  • [35] INDACATEROL FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    Cazzola, M.
    Proietto, A.
    Matera, M. G.
    DRUGS OF TODAY, 2010, 46 (03) : 139 - 150
  • [36] Chronic obstructive pulmonary disease (COPD) - Introduction
    Zabel, P.
    INTERNIST, 2006, 47 (09): : 883 - 884
  • [37] Pathomechanisms in chronic obstructive pulmonary disease (COPD)
    Glaab, Thomas
    Hohlfeld, Jens M.
    Joerres, Rudolf A.
    Krug, Norbert
    Welte, Tobias
    MEDIZINISCHE KLINIK, 2006, 101 (12) : 951 - 956
  • [38] Chronic obstructive pulmonary disease (COPD) and sleep
    Galetke, Wolfgang
    SOMNOLOGIE, 2020, 24 (01): : 5 - 10
  • [39] Evaluation of quality of medication use in chronic obstructive pulmonary disease (COPD): development and validation of an audit tool
    Wong, Pei Se
    Eliasson, Frida
    Perry, Lorraine
    Loh, Richard L. C.
    Hudson, Stephen
    PHARMACY WORLD & SCIENCE, 2009, 31 (01): : 123 - 123
  • [40] Development of national curriculum guidelines using a modified RAND/UCLA appropriateness method
    Hill, Sophie
    Rusaw, David F.
    Goihl, Tobias
    Hjerman, Anne Katrine
    Schwannborg, Linn Reed
    Bauge, Krister
    QUALITY IN HIGHER EDUCATION, 2020, 26 (03) : 323 - 336